Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|July 29, 2023
Coronary Vascular (DYS) Function and Invasive Physiology Assessment: Insights into Bolus and Continuous Thermodilution MethodsMatteo Maurina, Alice Benedetti, Giulio Stefanini, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 26, 2017
Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branchesValeria Paradies, Pieter C Smits, Georgios J Vachojannis, et al.
The American Journal of Cardiology|October 27, 2018
Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation LesionsValeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, et al.
International Journal of Cardiology|May 19, 2019
Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trialValeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2011
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trialsDean J Kereiakes, Pieter C Smits, Elvin Kedhi, et al.
Circulation|August 10, 2011
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitusGregg W Stone, Elvin Kedhi, Dean J Kereiakes, et al.
Nature Clinical Practice. Cardiovascular Medicine|February 28, 2006
Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loopsPaul Steendijk, Pieter C Smits, Marco Valgimigli, et al.
Journal of the American College of Cardiology|April 26, 2011
2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)Pieter C Smits, Elvin Kedhi, Kees-Jan Royaards, et al.
International Journal of Cardiology|December 11, 2012
Do we have a future with transcatheter adventitial delivery of stem cells?Alexander N Kharlamov, Henricus J Duckers, Heleen M M van Beusekom, et al.
JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) TrialsDavid Planer, Pieter C Smits, Dean J Kereiakes, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|July 29, 2023
Coronary Vascular (DYS) Function and Invasive Physiology Assessment: Insights into Bolus and Continuous Thermodilution MethodsMatteo Maurina, Alice Benedetti, Giulio Stefanini, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 26, 2017
Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branchesValeria Paradies, Pieter C Smits, Georgios J Vachojannis, et al.
The American Journal of Cardiology|October 27, 2018
Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation LesionsValeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, et al.
International Journal of Cardiology|May 19, 2019
Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trialValeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2011
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trialsDean J Kereiakes, Pieter C Smits, Elvin Kedhi, et al.
Circulation|August 10, 2011
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitusGregg W Stone, Elvin Kedhi, Dean J Kereiakes, et al.
Nature Clinical Practice. Cardiovascular Medicine|February 28, 2006
Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loopsPaul Steendijk, Pieter C Smits, Marco Valgimigli, et al.
Journal of the American College of Cardiology|April 26, 2011
2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)Pieter C Smits, Elvin Kedhi, Kees-Jan Royaards, et al.
International Journal of Cardiology|December 11, 2012
Do we have a future with transcatheter adventitial delivery of stem cells?Alexander N Kharlamov, Henricus J Duckers, Heleen M M van Beusekom, et al.
JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) TrialsDavid Planer, Pieter C Smits, Dean J Kereiakes, et al.
Pageof 19